Evaluation of the efficacy and safety of long-term use of Opicapone

Opicapone is a new, long-acting catechol-O-methyltransferase (COMT) inhibitor, mainly used for adjuvant treatment of patients with Parkinson's disease during the "on-off" fluctuation period. Its mechanism of action is to inhibit peripheral COMT enzyme activity, thereby prolonging the half-life of levodopa in the body, stabilizing its blood concentration, and alleviating the "off period" symptoms of Parkinson's disease. Long-term administration of Opicapone has demonstrated good durability and tolerability in multiple studies and real-world data around the world.

In terms of efficacy, Opicapone has an obvious “on-period” prolongation effect, and is especially suitable for patients with levodopa treatment but penetration phenomenon. Its once-daily dosing frequency is significantly better than that of early COMT inhibitors such as Entacapone, which not only enhances patient compliance but also reduces unstable blood concentration problems caused by frequent medication. After long-term use of Opicapone, most patients achieve sustained improvements in symptom control, especially in terms of daytime activity and quality of life.

In terms of safety, Opicapone was originally designed to avoid problems such as hepatotoxicity and gastrointestinal discomfort that are common with older generationCOMT inhibitors. Clinical observation shows that even if it is used continuously for more than 12 months, its impact on liver function is still minimal, and the serum liver enzyme levels of most patients remain within a safe range. Furthermore, the incidence of psychiatric abnormalities or motor complications was not significantly increased when used concomitantly with levodopa. Compared with traditional treatment options, long-term use of opicapone has not seen serious accumulation or resistance problems.

It should be pointed out that although opicapone has a good safety profile, its efficacy still relies on a reasonable combination with levodopa. Individualized adjustment is the key to improving long-term treatment effects. Some patients need to moderately adjust the dose of levodopa during initial use to avoid motor side effects caused by excessive levodopa enhancement.

Reference materials:https://www.ongentys.com/